Carl Zeiss Meditec AG / Key word(s): Quarter Results 05.01.2015 12:29 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Carl Zeiss Meditec achieves double-digit revenue growth in Q1 2014/15 Jena, 05 January 2015: Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of approximately EUR 240 million in Q1 2014/15, based on preliminary data. This corresponds to growth of around 13% over the previous year. Currency effects, particularly from the EUR/USD exchange rate, have contributed to this result. Adjusted for currency and acquisition effects the revenue increase amounts to approximately 8% over the previous year. Earnings before Interest & Taxes (EBIT) for Q1 2014/15 are expected to be above the previous year's value of EUR 26.5 million. Contact for investors Sebastian Frericks, Director Investor Relations, Carl Zeiss Meditec AG Tel. +49 3641 220-116, E-Mail: [email protected] Press contact Jann Gerrit Ohlendorf, Director Corporate Communications, Carl Zeiss Meditec AG Tel. +49 3641 220-331, E-Mail: [email protected] 05.01.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena Germany Phone: +49 (0)3641 220-0 Fax: +49 (0)3641 220-112 E-mail: [email protected],[email protected] Internet: www.meditec.zeiss.de ISIN: DE0005313704 WKN: 531370 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------